Vivani Medical, Inc. Common Stock (DE) (VANI) is a publicly traded Healthcare sector company. As of October 12, 2026, VANI trades at $1.25 with a market cap of $112.75M and a P/E ratio of -2.83. VANI moved +0.00% today. Year to date, VANI is +1.63%; over the trailing twelve months it is -11.35%. Its 52-week range spans $0.91 to $1.92. Analyst consensus is buy with an average price target of $4.00. Rallies surfaces VANI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Vivani Medical to present at ThinkEquity Conference: Vivani Medical will attend the Maxim Growth Summit on Oct. 14 and the ThinkEquity Conference on Oct. 15, both in New York. CEO Adam Mendelsohn is scheduled to present at ThinkEquity.
| Metric | Value |
|---|---|
| Price | $1.25 |
| Market Cap | $112.75M |
| P/E Ratio | -2.83 |
| EPS | $-0.43 |
| Dividend Yield | 0.00% |
| 52-Week High | $1.92 |
| 52-Week Low | $0.91 |
| Volume | 30 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-26.61M |
| Gross Margin | 0.00% |
2 analysts cover VANI: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $4.00.